InvestorsHub Logo
Followers 2
Posts 25
Boards Moderated 0
Alias Born 05/05/2014

Re: None

Wednesday, 06/25/2014 12:37:41 PM

Wednesday, June 25, 2014 12:37:41 PM

Post# of 2191
ZLCS will bring an estimated $9-12 million to the merged company and a potential 17 million with residuals. Epirus has received $36 million in financing in april 2014. Combined with exciting drug approved in India and we should see quite a run once the financials are released as a new company. Money in the bank from $1.26 way too cheap.